|
|
||||||||

1 Department of Pediatrics
2 Department of Microbiology
3 Department of Pathology
and4 Department of Medicine, State University of New York
5 Division of Infectious Diseases and Microbiology Laboratories, Children's Hospital, Buffalo, New York 14222
and6 Kidney Research Laboratory, Buffalo General Hospital, Buffalo, New York 14209, U.S.A.
Groups of mice were immunized intraperitoneally with HEp-2 lysate or respiratory syncytial virus (RSV)-infected HEp-2 cells with or without adjuvant(s). The animals were subsequently challenged intranasally (i.n.) with RSV and/or HEp-2 lysate and studied for RSV shedding in the lung, antigen-specific antibody response and pulmonary histopathology. A significant decrease in virus shedding was detected in each of four groups of animals immunized with a virus preparation and in two of four groups that received a HEp-2 lysate. Mice immunized with adjuvant(s) developed higher antibody-specific responses. All vaccinated animals developed pulmonary histopathology only on subsequent i.n. inoculation with RSV and/or HEp-2 lysate. Denatured extracts of purified RSV, HEp-2, BALB/c lung, cotton rat lung, Buffalo green monkey kidney and human buccal epithelium were tested for reactivity against the sera of immunized mice by an immunoblot method. Sera from all groups of immunized mice reacted with the extracts tested. The data suggest a possible role of reactivity to viral as well as non-viral components in the pathogenesis of RSV vaccine-induced pulmonary inflammation in the mouse model system.
Keywords: RSV, immune response, inflammatory cells
Present address: Department of Microbiology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, Tex. 77030, U.S.A.
Received 5 July 1988;
accepted 17 October 1988.
This article has been cited by other articles:
![]() |
S. M. Castro, A. Guerrero-Plata, G. Suarez-Real, P. A. Adegboyega, G. N. Colasurdo, A. M. Khan, R. P. Garofalo, and A. Casola Antioxidant Treatment Ameliorates Respiratory Syncytial Virus-induced Disease and Lung Inflammation Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1361 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Prince, S. J. Curtis, K. C. Yim, and D. D. Porter Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine J. Gen. Virol., December 1, 2001; 82(12): 2881 - 2888. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |